ArticleOncoTargets and therapy2025

Lowering the Selinexor Dose within the Pomalidomide and Dexamethasone Combination Regimen Elicits Fewer Side Effects While Comparable Efficacy Against Relapsed/Refractory Multiple Myeloma.

Liying Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.